Yemen

in page functions: [French]

Total population (2017)	28,119,471
Birth cohort (2017)	866,557
Surviving Infants (surviving to 1 year per year, 2017)	824,145
Infant mortality rate (deaths < 1 year per 1000 births, 2015)	34/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015)	42/1000
World Bank Index, IDA (2015)	2.61
Gross Nation Income (per capita US$, 2015)	1,140
Co-financing group (2017)	Preparatory transition
No. of districts/territories (2015)	333

Download this page as a PDF factsheet

Yemen

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Yemen

Type of support	Approvals 2001-2021 (US$) (29 Jun 2017)	Commitments 2001-2021 (US$) (29 Jun 2017)	Disbursements 2000-2017 (US$) (29 Jun 2017)	% Disbursed (29 Jun 2017)


Total	$230,086,993	$235,619,415	$226,210,688
Health system strengthening (HSS 1)	$6,335,000	$6,335,000	$6,335,000	100%
Health system strengthening (HSS 2)	$14,279,312	$17,639,234	$12,948,232	91%
Immunisation services support (ISS)	$5,049,500	$5,049,500	$5,049,500	100%
Injection Safety Devices (NVS)	$313,000	$313,000	$396,937	127%
Injection safety support (INS)	$1,194,757	$1,194,757	$1,194,757	100%
IPV (NVS)	$3,786,991	$5,959,491	$2,502,722	66%
Measles-Rubella (NVS)	$8,313,136	$8,313,136	$8,313,136	100%
MR - Operational costs (OPC)	$7,533,500	$7,533,500	$7,533,500	100%
Penta (NVS)	$72,252,487	$72,252,487	$73,356,038	102%
Pneumo (NVS)	$89,260,528	$89,260,528	$87,956,283	99%
Rotavirus (NVS)	$19,659,782	$19,659,782	$18,515,583	94%
Vaccine Introduction Grant (VIG)	$2,109,000	$2,109,000	$2,109,000	100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Yemen DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015) Grade of confidence	N/A
DTP3 - Official country estimates (2015)	84%
M:F sex ratio at birth (2017)	1.05
Household survey: DTP3 coverage for male (2012)	59.70%
Household survey: DTP3 coverage for female (2012)	59.60%
Household survey: Last DTP3 survey (2012)	60%
% districts achieving > 80% DTP3 coverage (2015)	64%
% districts achieving < 50% DTP3 coverage (2015)	10%
MCV WHO/UNICEF estimates (2015)	67%

Breakdown of support

Non-vaccine support	Vaccine support
16%	84%
$35,169,989	$191,040,699

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Yemen

15 June 2017

Gavi to help protect millions more children against polio

Gavi Board agrees to extend support for inactivated polio vaccine (IPV) to 2020; new policy on fragile settings, emergencies and refugees also approved.

08 November 2016